This topic contains a solution. Click here to go to the answer

Author Question: Which of the following strategies is appropriate for companies in industries where buyer preferences ... (Read 58 times)

crobinson2013

  • Hero Member
  • *****
  • Posts: 535
Which of the following strategies is appropriate for companies in industries where buyer preferences do not converge across national borders?
 
  A) retrenchment strategy
  B) global strategy
  C) multidomestic strategy
  D) mass customization strategy

Question 2

Companies often establish largely independent, self-contained units in each of its national markets to implement a ________ strategy.
 
  A) retrenchment
  B) global
  C) multinational
  D) blue ocean



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

duke02

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

C

Answer to Question 2

C




crobinson2013

  • Member
  • Posts: 535
Reply 2 on: Jul 7, 2018
Gracias!


momolu

  • Member
  • Posts: 320
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The modern decimal position system was the invention of the Hindus (around 800 AD), involving the placing of numerals to indicate their value (units, tens, hundreds, and so on).

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library